# Fred C. Lam

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/fred-c-lam/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,833 |
| Field | Brain Metastases and Treatment |
| h-index | 22 |
| i10-index | 38 |
| Last Known Institution | Stanford Medicine |
| OpenAlex ID | https://openalex.org/A5024414501 |
| Works | 143 |

## Researcher papers

- [β‐Amyloid efflux mediated by p‐glycoprotein](https://scholariq.org/papers/amyloid-efflux-mediated-by-p-glycoprotein/)
- [The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury](https://scholariq.org/papers/the-dna-sensing-aim2-inflammasome-controls-radiation-induced-cell-death-and/)
- [The bromodomain protein Brd4 insulates chromatin from DNA damage signalling](https://scholariq.org/papers/the-bromodomain-protein-brd4-insulates-chromatin-from-dna-damage-signalling/)
- [Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles](https://scholariq.org/papers/enhanced-efficacy-of-combined-temozolomide-and-bromodomain-inhibitor-therapy-for/)
- [BRD4 prevents the accumulation of R-loops and protects against transcription–replication collision events and DNA damage](https://scholariq.org/papers/brd4-prevents-the-accumulation-of-r-loops-and-protects-against-transcription/)
- [Regulation of Amyloid Precursor Protein Catabolism Involves the Mitogen-Activated Protein Kinase Signal Transduction Pathway](https://scholariq.org/papers/regulation-of-amyloid-precursor-protein-catabolism-involves-the-mitogen/)
- [Area method for the estimation of partition coefficients for physiological pharmacokinetic models](https://scholariq.org/papers/area-method-for-the-estimation-of-partition-coefficients-for-physiological/)
- [Augmented Autologous Pericranium Duraplasty in 100 Posterior Fossa Surgeries—A Retrospective Case Series](https://scholariq.org/papers/augmented-autologous-pericranium-duraplasty-in-100-posterior-fossa-surgeries-a/)
- [Ascending Single‐Dose, Double‐Blind, Placebo‐Controlled Safety Study of Noribogaine in Opioid‐Dependent Patients](https://scholariq.org/papers/ascending-single-dose-double-blind-placebo-controlled-safety-study-of/)
- [Ascending-dose study of noribogaine in healthy volunteers: Pharmacokinetics, pharmacodynamics, safety, and tolerability](https://scholariq.org/papers/ascending-dose-study-of-noribogaine-in-healthy-volunteers-pharmacokinetics/)

## Researcher topics

- [Brain Metastases and Treatment](https://scholariq.org/topics/brain-metastases-and-treatment/)
- [Glioma Diagnosis and Treatment](https://scholariq.org/topics/glioma-diagnosis-and-treatment/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)
- [Management of metastatic bone disease](https://scholariq.org/topics/management-of-metastatic-bone-disease/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Researcher university

- [Stanford Medicine](https://scholariq.org/institutions/stanford-medicine/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.